WORCESTER, Mass., Jan. 27, 2009 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation (Nasdaq:GNBT) (www.generex.com), the leader in drug delivery for metabolic diseases through the inner lining of the mouth, today announced its participation in the 2009 Arab Health Congress (http://www.arabhealthonline.com/congress/index.html) taking place January 26 - 29 at the Dubai International Convention & Exhibition Centre. Generex is participating in the congress through its Middle Eastern branch office, Generex MENA (Middle East and Northern Africa), which received a Commercial License from the Government of Dubai, United Arab Emirates in 2008 and opened an office in Dubai Healthcare City.
